Top 4 NASDAQ Stocks In The Diagnostic Substances Industry With The Highest Operating Margin - Neogen (NASDAQ:NEOG)

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.

Below are the top diagnostic substances stocks on the NASDAQ in terms of operating margin.The trailing-twelve-month operating margin at SurModics, Inc. (NASDAQ: SRDX) is 33.60 percent. SurModics' PEG ratio is 2.06.The trailing-twelve-month operating margin at Meridian Bioscience, Inc. (NASDAQ: VIVO) is 27.60 percent. Meridian Bioscience's revenue for the same period is $193.50 million.The trailing-twelve-month operating margin at AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) is 22.30 percent. AMAG Pharmaceuticals' EPS for the same period is $4.40.The trailing-twelve-month operating margin at Neogen Corporation (NASDAQ: NEOG) is 18.20 percent. Neogen's ROE for the same period is 9.80 percent.

Crypto Whales Are Loading Up — Are You?

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!